+ Watch AMRS
on My Watchlist
Short. Former Biopharma company, now specialty chem. Revs down 73% Issuing tons of stock and debt.
Advanced Quantitative Momentum Arbitrage (AQMA)(black box)
Biofuel>> until the company produces for the market it will be speculative, but when it does it might be too late to get in ~early.
Its a strong company with many potential technologies. Green tech is growing rapidly
It is a biochemical company which can turn plant sugars into more valuable commodities using designer microbes, an entirely new human capability. The company is ran by idealistic, practical leaders, with special strength in several nations, e.g. Brazil.
AMRS is undervalued at these levels. There is resistance at the $20.50 level. If it breaks $21 is could squirt all the way to $30 in no time. They are well backed and respected in the VC community.
On the cusp of profitability and have gained capital through the IPO.
Weakening Earnings Opinion
Here's the buy rec:http://www.fool.com/investing/high-growth/2011/01/27/rising-star-buy-amyris-biotechnologies.aspx
The long term arc is that oil is going to cost more and more to extract. This company's products OTOH need no refining and have an abundantly available feedstock. They can be shunted into pathways for use as gasoline, diesel, or jet fuel substitutes and exceed the original's performance. And eventually aviation will be charged for its carbon emissions as well, justifying an additional premium for this alternative.Meanwhile the company will eke by at first by producing other specialty products as they get their production costs down and the costs of oil and associated with its use go up. I suspect that "capital light" may even eventually mean selling just the bugs as IP.A long term play but worth it for an investor with tolerance for risk and a long term horizon.
reports their ( at $16.00) first quarterly earnings report since their IPO(October 2, 2010) on November 4th after the close.. They will be touting , I'm sure , how far along they are in their new biofuel facilities in Brazil, as well as their joint venture partners, Vale, as well as other important companies invested with them. A video will be played 2 hrs after the report on their website.
Sugar for energy! California company,17% owned by TOT(Total of France)which has joint venture with Santelisa Vale of Brazil. Was a recent IPO at $16.00, priced below initial expectations, and hasn't performed well since. This is a long term play and requires much patience! They are using yeast to turn sugar into biodiesal, which is more widely used than ethanol, and doesn't have the same trade restrictions that ethanol has, as it doesn't compete with corn production.
biofuel operations in Brazil, partnering with Vale the #2 sugar producer in the world. Was a recent IPO that hasn't attracted too much attention...yet...OIL will not stay under $100 barrell for long!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions